'Pharma Bro' Martin Shkreli is streaming his stock trades — now the FTC and seven states are coming after him

Rinna DiamantakosThu, October 15, 2026 at 4:00 PM UTC

0

The convicted felon, who spent more than four years in prison for defrauding investors, has caught the attention of state and federal authorities once again.

“Pharma Bro” Martin Shkreli is facing fresh legal action — this time for allegedly violating a 2022 civil court order banning him from the pharmaceutical industry for life.

Shkreli gained international attention — and his nickname — after he hiked the price of a life-saving drug back in 2015. The 43-year-old was then sentenced to prison in 2017 for securities fraud in a case unrelated to his price-hiking scandal and was released in 2022. He has since made a career off of livestreaming his stock trades, which allegedly include at least 60 pharmaceutical-related stocks.

Must Read -

A single line on your car insurance policy could be inflating your premium by up to 30% — here's what to change

Dave Ramsey warns nearly 50% of Americans are making 1 big Social Security mistake. Here’s what it is and 3 simple steps to fix it ASAP

Jeff Bezos backs a platform that lets anyone invest in rental homes for as little as $100 — 6 ways to build wealth like a landlord without actually being one

The Federal Trade Commission (FTC) and seven states are accusing Shkreli of violating his lifetime ban by publicly trading in the industry and “broadcasting his opinions about the business and management of many Pharmaceutical Companies through livestreaming and posting on numerous social media platforms, including YouTube, X and Reddit,” according to CNBC.

Shkreli currently has over 641,000 followers on X, as well as more than 95,000 subscribers on YouTube. His livestreams regularly attract thousands of viewers.

Shkreli’s conviction

Shkreli was convicted in 2017 for two counts of securities fraud and one count of conspiracy after he was caught defrauding investors related to his two hedge funds and pharmaceutical company. Shkreli was sentenced to seven years in prison — he was released after four years and three months — and faced up to $7.3 million in fines.

But Shkreil gained notoriety long before his prison sentence. In 2015, the then pharmaceutical entrepreneur acquired a drug called Daraprim, a life-saving medication used to treat parasitic infections, and hiked the price from $13.50 to $750 per tablet. According to the New York Times, the move earned him the nickname “pharma bro” due to his harsh attitude despite facing widespread criticism.

Advertisement

Read More: Here’s the average income of Americans by age in 2026. Are you keeping up or falling behind?

In 2022, a judge ruled Shkreli tried to maintain a monopoly over the drug by using anticompetitive tactics. The judge also found that he had violated state and federal antitrust laws and that his former pharmaceutical company brought in $64.6 million in profits through these practices.

He was ordered to repay the entirety of the profits to victims and was barred for life from the pharmaceutical industry.

Shrekli’s alleged violation

The FTC and seven states — California, New York, North Carolina, Illinois, Ohio, Virginia and Pennsylvania — say Shkreli began allegedly violating the court’s ban almost immediately after he was released from prison in May 2022.

On Oct. 13, the FTC asked a federal judge to hold Shkreli in contempt and fine him the total profits he made from his trades. They are also asking a judge to force him to divest from any pharmaceutical company stocks he currently owns and for him to face escalating consequences for any future violations, including possible jail time.

What To Read Next -

Your Social Security ‘Trump Bump’ in 2027 will be one of the biggest in 25 years — but there’s a serious catch no one’s talking about

Dave Ramsey says this 1 indulgent purchase stops Americans from becoming wealthy. Here’s what he recommends instead

The tax breaks in Trump's 'big beautiful bill' expire after 2028. Here are 4 moves to make before the window closes

Your cash is rotting in a regular savings account. Here are 4 simple ways to grow your money (and no, you don't have to touch the stock market)

Get Warren Buffett's best investing lessons, free. Join 250,000 readers getting Moneywise’s sharpest money reporting every week. Subscribe and we’ll send you our guide to the ideas that built Buffett's fortune as a welcome gift.

This article provides information only and should not be construed as advice. It is provided without warranty of any kind.

Original Article on Source

Source: “AOL Money”